Hypertension: causes and consequences of circadian rhythms in blood pressure
FM Faraci, FAJL Scheer - Circulation Research, 2024 - Am Heart Assoc
Hypertension is extremely common, affecting approximately 1 in every 2 adults globally.
Chronic hypertension is the leading modifiable risk factor for cardiovascular disease and …
Chronic hypertension is the leading modifiable risk factor for cardiovascular disease and …
[HTML][HTML] Pathophysiology of cerebral small vessel disease: a journey through recent discoveries
Cerebral small vessel disease (cSVD) encompasses a heterogeneous group of age-related
small vessel pathologies that affect multiple regions. Disease manifestations range from …
small vessel pathologies that affect multiple regions. Disease manifestations range from …
Impact of arterial stiffness on cerebrovascular function: a review of evidence from humans and preclinical models
With advancing age, the cerebral vasculature becomes dysfunctional, and this dysfunction is
associated with cognitive decline. However, the initiating cause of these age-related …
associated with cognitive decline. However, the initiating cause of these age-related …
[HTML][HTML] Molecular Mechanisms Underlying Vascular Remodeling in Hypertension
X Zeng, Y Yang - Reviews in Cardiovascular Medicine, 2024 - imrpress.com
Hypertension, a common cardiovascular disease, is primarily characterized by vascular
remodeling. Recent extensive research has led to significant progress in understanding its …
remodeling. Recent extensive research has led to significant progress in understanding its …
[HTML][HTML] Twenty-four-hour ambulatory blood pressure monitoring–from silent to whispering brain damage
T Yaneva-Sirakova, I Petrov, L Traykov, A Coca… - 2023 - Taylor & Francis
A significant number of antihypertensive drugs have been developed to inhibit putative
neurohormonal mechanisms involved in the pathogenesis of hypertension. However, the BP …
neurohormonal mechanisms involved in the pathogenesis of hypertension. However, the BP …
[PDF][PDF] Hypertonie
T Yanevka-Sirakova, I Petrov, L Traykov, A Coca… - Journal of …, 2024 - kup.at
Nahezu alle antihypertensiven Medikamenten wurde ent wickelt, um neurohumorale
Mechanismen zu inhibieren, von denen angenommen wird, dass sie in die Pathogene se …
Mechanismen zu inhibieren, von denen angenommen wird, dass sie in die Pathogene se …